Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Progress Across TSHA-102 ...

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to Reached written alignment with FDA on inclusion of =3 months of safety data from ASPIRE trial evaluating TSHA-102 (N=3 ...
Medindia

Diabetes Mellitus Could Cost the World Trillions by 2050

Diabetes mellitus could drain tens of trillions from the global economy, with informal caregiving emerging as the largest ...